• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Ask the Editor

Ask the Editor

September 1, 2018
Chris Aiken, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Chris Aiken, MD Editor-in-Chief of The Carlat Psychiatry Report Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Starting with this issue, Editor-in-Chief Chris Aiken, MD, will give advice on a different practice challenge. If you have a question you’d like Dr. Aiken to answer, please send an email to AskTheEditor@thecarlatreport.com.

Dr. Aiken won’t be able to answer all questions received, but he will pick one each month that is of general interest.

Medication-Induced Hyponatremia
Dear Dr. Aiken: Can you tell us more about hyponatremia? Which medications can cause hyponatremia, who’s at risk, and how we should manage this condition?

Dr. Aiken: Hyponatremia, or low sodium level, is a rare but serious side effect of certain psychiatric medicines. The following is some information that I hope will help:

Which medications cause hyponatremia?
Oxcarbazepine (30% for mild; 1.3% for significant) and carbamazepine (15% mild; 0.1% significant). SSRIs, SNRIs, and antipsychotics cause hyponatremia at much lower rates (around 1:2,000).

Who’s at risk?
Age >45, thiazide diuretic use, renal or kidney disease. Hyponatremia is common in schizophrenia (lifetime rate 10%) due in part to psychogenic polydipsia, a psychotic syndrome where patients drink water compulsively.

What are the symptoms?
Nausea, dizziness, memory problems, malaise, fatigue, and headaches. Usually the drop in sodium is gradual, causing mild symptoms, but the presentation can be dramatic when the sodium falls over a few days. Either way, hyponatremia has serious consequences if left untreated: seizures, rhabdomyolysis, brain stem myelinolysis, and death.

How do you interpret the level?
Decreased sodium can be mild (<135 Meq/L) or severe (<125 Meq/L).

Management tips
If sodium <125 Meq/L or the symptoms are severe, send to ED. Otherwise, stop the causative medication, restrict fluids (1–1.5 L/day), and recheck sodium in 1 week. Lithium levels can rise during hyponatremia, so hold that medicine and check a level if the patient is taking it. Refer to nephrology if the problem persists. When the offending medication can’t be stopped, the ADH inhibitor demeclocycline (600–1200 mg/day) can be added in consultation with nephrology.

Sources: Yang HJ et al, Psychopharmacology (Berl) 2017;234(5):869–876. Annamalai A, Medical Management of Psychotropic Side Effects. New York, NY: Springer; 2017.
General Psychiatry
KEYWORDS practice_tools_and_tips
Aiken eic 150x150
Chris Aiken, MD

Psychopharm Commandment #6: MAOIs

More from this author
www.thecarlatreport.com
Issue Date: September 1, 2018
SUBSCRIBE NOW
Table Of Contents
CME Post-Test - Emergency Psychiatry, TCPR, September 2018
Ask the Editor
Serotonin Syndrome Risks With Co-Prescription of Triptan Drugs and SSRIs or SNRIs
Mindfulness Therapy for Adult ADHD
Benzodiazepines: New Risks for an Old Drug
Calming Agitated Patients in an Emergency
The 10 Commandments for Verbal De-Escalation
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.